CHM 0.00% 1.0¢ chimeric therapeutics limited

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-47

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,217 Posts.
    lightbulb Created with Sketch. 3896
    How dare you being positive over here? Didn't you get the memo? The end is apparently near, forget the clinical results thus far, the preclinical data - meaningless, and 5 ongoing clinical trials - trash.

    All this talk of trash now even got "smelly-finger-bottom-picker" interested to invest his wife's money, instead of spending his weekly allowance on Tiprank and lollies. Alarm bells are ringing in my head as I type this.

    Then again, looking at the pros (see above and previous posts from @dalts66, @Shellbell etc.) and cons (uhm... from what I can gather the dark lord of Oncology himself plus maybe the current cash situation - but mostly the dark lord), I'm comfortable buying more for now.

    "One two, Hopper's coming for you..."
    Last edited by pfeifer1982: 04/06/24
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $9.951M
Open High Low Value Volume
1.0¢ 1.1¢ 1.0¢ $20.60K 1.964M

Buyers (Bids)

No. Vol. Price($)
2 2834404 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 362909 8
View Market Depth
Last trade - 15.28pm 12/11/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.